Heart scan AI spots silent liver threat

NCT ID NCT07216859

Summary

This study is testing whether artificial intelligence (AI) can find early signs of fatty liver disease by analyzing routine heart ultrasound images. It will enroll 2000 adults who have already had a heart scan. The main goal is to see if this AI tool helps doctors diagnose liver problems faster and get patients started on treatment sooner than usual care.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Cedars-Sinai Medical Center

    Los Angeles, California, 90034, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Kaiser Permanente

    Pleasanton, California, 94588, United States

    Contact Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Stanford Healthcare

    Palo Alto, California, 94588, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.